BC Week In Review | Nov 10, 2014
Clinical News

Ebola tablet vaccine: Phase I start

In 1Q15, Vaxart plans to begin clinical trials of its Ebola tablet vaccine. Vaxart Inc. , San Francisco, Calif.   Product: Ebola tablet vaccine   Business: Infectious   Molecular target: NA   Description: Tablet vaccine containing...
Items per page:
1 - 1 of 1